Pharmafile Logo

Content for all – how to connect with neurodiverse audiences

Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.

Group of friends chatting

Most written content is generally designed and presented for a neurotypical audience. This means that for the 1 in 5 people who are neurodivergent,1 engaging with written content can be a daily challenge.

Accessible and inclusive content is vital in creating equity and embracing diversity. The good news is that there are many ways to support neurodivergent individuals to process information being communicated. In this blog, we will explore three ways to support the development of accessible content for neurodivergent readers.

Key strategies for inclusive content

  1. Prioritise the style and appearance of written information

The readability of content begins with choosing the right font and layout.Sans serif fonts like Arial, Verdana, and Calibri are most inclusive for a neurodiverse audience. This is because they make letters look less crowded, which can facilitate understanding and speed of reading.

There are other ways to improve the style and appearance of writing too:2,3

Do and Don't checklist

  1. Use colours that consider sensory processing differences

Colour plays a crucial role in how content is perceived and processed by neurodivergent audiences. It is important to avoid sensory-loaded and highly saturated colours such as red and yellow in designs since they may trigger sensory overload in some readers. Greens, blues, muted pastel and neutral tones are better to choose from because they are less stimulating and evoke feelings of peace and tranquillity.4,5

Muted tone colour swatch

High contrast colours such as white and pure black on printed materials can be dazzling and visually stressful for neurodivergent readers. Instead, a light background with dark grey text can help with readability. The same is true for digital materials, whilst giving the option to switch the interface between light and dark mode or to a specific hue saturation can help enormously.6

  1. Use visuals and graphics to communicate information

Concise writing that avoids metaphors and figurative language as well as visual aids can significantly enhance attention, comprehension and retention for neurodivergent readers.7,8

Visual elements act as cues and bring structure and sequence to writing. Icons and images placed throughout documents can also help to anchor words to the page and help readers navigate through a written resource more efficiently. Icons and images may also help form memories and improve understanding.2

While traditional content often caters to neurotypical audiences, making small adjustments in font choice, colour use, and visual aids can create a more inclusive experience for neurodivergent readers. For more detailed guidelines on creating accessible content, explore resources from the Neurodiversity Design System, Inclusion & Accessibility Labs, and the British Dyslexia Association.

At Cuttsy+Cuttsy, we are committed to making healthcare communications accessible for everyone. Please get in touch if you’d like to find out more about the work we do.

 

References

1.    The Brain Charity (2022). Accessed: September 2024.

2.    British Dyslexia Association (2023). Accessed: September 2024.

3.    Dyslexia Support South (2023). Accessed: September 2024.

4.    Full Fabric (2024). Accessed: September 2024.

5.    Experia (2021). Accessed: September 2024.

6.    Neurodiversity Design System (2024). Accessed: September 2024.

7.    Fighting Talk Communications (2024). Accessed: September 2024.

8.    Bedrock Learning (2022). Accessed: September 2024.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Permission to pause: making treatment breaks part of the cancer care conversation

Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.

A seat at the table: what the EU HTA reforms really ask of patient involvement

The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at the table.

Why faster trials make participant understanding more important than ever

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.

Older trial participants reject bad design, not technology

Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences that make participation harder.

5 key takeaways from the Patient Centricity and Engagement Conference

Key takeaways from the Patient Centricity and Engagement conference, exploring how trust, inclusion and meaningful partnership can help turn patient engagement from intention into action.

It’s time to stop calling adverse events ‘manageable’

A single word—manageable—can minimise the real burden of treatment side effects, and it’s time clinical trial communication reflected patients’ lived experience more clearly.

The value: why localisation pays off across global trials

Strong localisation reduces trial friction, supports site teams, improves participant understanding and helps global studies run more smoothly, fairly and efficiently.

The solution: Good localisation doesn’t feel translated

Learn what good localisation looks like in clinical trials and why participant-facing materials should feel naturally relevant, culturally appropriate and easy to understand across every market.

Healthcare information is becoming easier to access. Trust isn’t.

Sharing key insights from NEXT Pharma Summit on why trust, clarity and human-centred communication matter more than ever in healthcare.

It was never reluctance: What ASCO 2026 revealed about clinical trial recruitment

ASCO 2026 highlighted that low clinical trial recruitment is driven less by patient reluctance and more by gaps in awareness, communication, accessibility and patient education.